Erysipelas medical therapy: Difference between revisions

	Erysipelas Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Erysipelas from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Electrocardiogram
X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Erysipelas medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Erysipelas medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Erysipelas medical therapy
CDC on Erysipelas medical therapy
Erysipelas medical therapy in the news
Blogs on Erysipelas medical therapy
Directions to Hospitals Treating Erysipelas
Risk calculators and risk factors for Erysipelas medical therapy

VisualWikitext

Latest revision as of 21:39, 29 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Luke Rusowicz-Orazem, B.S. Maliha Shakil, M.D. [2]

Overview

The mainstay of therapy for erysipelas is antimicrobial therapy. Pharmacologic therapy for erysipelas includes either Penicillins, Erythromycin, or Cephalosporins. Empiric therapy for facial erysipelas includes either Vancomycin, Daptomycin, or Linezolid.

Medical Therapy

Antimicrobial Regimen

Erysipelas^[1]

1. Adults

Preferred regimen (1): Penicillin 500 mg PO qid
Preferred regimen (2): Amoxicillin 500 mg PO qid
Preferred regimen (3): Erythromycin 250 mg PO qid
Preferred regimen (4): Ceftriaxone 1 g IV q24h
Preferred regimen (5): Cefazolin 1 to 2 g IV q8h

2. Pediatrics

Preferred regimen (1): Penicillin 25 to 50 mg/kg/day PO tid or qid
Preferred regimen (2): Amoxicillin 25 to 50 mg/kg/day PO tid
Preferred regimen (3): Erythromycin 30 to 50 mg/kg/day PO bid to qid
Preferred regimen (4): Ceftriaxone 50 to 75 mg/kg/day IV q12-24h
Preferred regimen (5): Cefazolin 100 mg/kg/day IV q8h

Facial erysipelas^[2]

1. Causative pathogens

Staphylococcus aureus
Streptococcus spp. (Group A, B, C, & G)
Enterobacteriaceae
Clostridium spp.

2. Empiric antimicrobial therapy

Preferred regimen: Vancomycin 1 g IV q12h
Alternative regimen: Daptomycin 4 mg/kg IV q24h OR Linezolid 600 mg IV q12h

References

↑ Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.
↑ Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.

Template:WS Template:WH

[pmid24947530-1] Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL; et al. (2014). "Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America". Clin Infect Dis. 59 (2): 147–59. doi:10.1093/cid/ciu296. PMID 24947530.

[2] Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.

[1]

[2]

@@ Line 1: / Line 1: @@
 __NOTOC__
+{{Erysipelas}}
+{{CMG}}; {{AE}} {{LRO}} {{Maliha}}
-{{Erysipelas}}
+==Overview==
-Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+The mainstay of therapy for erysipelas is [[antimicrobial]] therapy.  Pharmacologic therapy for erysipelas includes either [[Penicillins]], [[Erythromycin]], or [[Cephalosporins]].  Empiric therapy for facial erysipelas includes either [[Vancomycin]], [[Daptomycin]], or [[Linezolid]].
-{{CMG}}
+==Medical Therapy==
-==Overview==
+===Antimicrobial Regimen===
-Depending on the severity, treatment involves either oral or intravenous antibiotics, using either [[penicillin]]s, [[clindamycin]] or [[erythromycin]]. While illness symptoms resolve in a day or two, the skin may take weeks to return to normal.
+* Erysipelas<ref name="pmid24947530">{{cite journal| author=Stevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL et al.| title=Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. | journal=Clin Infect Dis | year= 2014 | volume= 59 | issue= 2 | pages= 147-59 | pmid=24947530 | doi=10.1093/cid/ciu296 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=24947530  }} </ref>
+:* 1. '''Adults'''
+::* Preferred regimen (1): [[Penicillin]] 500 mg PO qid
+::* Preferred regimen (2): [[Amoxicillin]] 500 mg PO qid
+::* Preferred regimen (3): [[Erythromycin]] 250 mg PO qid
+::* Preferred regimen (4): [[Ceftriaxone]] 1 g IV q24h
+::* Preferred regimen (5): [[Cefazolin]] 1 to 2 g IV q8h
+:* 2. '''Pediatrics'''
+::* Preferred regimen (1): [[Penicillin]] 25 to 50 mg/kg/day PO tid or qid
+::* Preferred regimen (2): [[Amoxicillin]] 25 to 50 mg/kg/day PO tid
+::* Preferred regimen (3): [[Erythromycin]] 30 to 50 mg/kg/day PO bid to qid
+::* Preferred regimen (4): [[Ceftriaxone]] 50 to 75 mg/kg/day IV q12-24h
+::* Preferred regimen (5): [[Cefazolin]] 100 mg/kg/day IV q8h
+*'''Facial erysipelas'''<ref>{{cite book | last = Gilbert | first = David | title = The Sanford guide to antimicrobial therapy | publisher = Antimicrobial Therapy | location = Sperryville, Va | year = 2015 | isbn = 978-1930808843 }}</ref>
+:* '''1. Causative pathogens'''
+::* Staphylococcus aureus
+::* Streptococcus spp. (Group A, B, C, & G)
+::* Enterobacteriaceae
+::* Clostridium spp.
+:* '''2. Empiric antimicrobial therapy'''
+::* Preferred regimen: [[Vancomycin]] 1 g IV q12h
+::* Alternative regimen: [[Daptomycin]] 4 mg/kg IV q24h {{or}} [[Linezolid]] 600 mg IV q12h
 ==References==
+{{Reflist|2}}
-{{Reflist|2}}
+{{WS}}
-[[Category:Needs content]]
+{{WH}}
+[[Category:Dermatology]]
+[[Category:FinalQCRequired]]
+[[Category:Emergency medicine]]
 [[Category:Disease]]
+[[Category:Up-To-Date]]
 [[Category:Infectious disease]]
-[[Category:Dermatology]]